List of serched triples
A total of 22252 records found
#16632
middle Confidence
Subject:
FGF2
(Growth Factors)
→
correlates_with
→
Object:
histological_grades_of_malignancy
(Pathological grading)
Original: Basic FGF level#correlates with#histological grades of malignancy
#16631
middle Confidence
Subject:
immunostaining_markers
(Molecular diagnostic tools)
→
are_supportive_tools_for
→
Object:
histological_diagnosis
(Diagnostic Process)
Original: Immunostaining markers#are supportive tools for#histological diagnosis of GAFG
#16630
middle Confidence
Subject:
chief_cells
(Chief cell)
→
are_present_in
→
Object:
gastric_adenocarcinoma_of_fundic_gland_type
(Disease phenotype)
Original: gastric adenocarcinoma of fundic gland type#consists of#mixed proliferation of oxyntic and chief cells
#16629
middle Confidence
Subject:
oxyntic_cells
(Parietal cells (oxyntic))
→
are_present_in
→
Object:
gastric_adenocarcinoma_of_fundic_gland_type
(Disease phenotype)
Original: gastric adenocarcinoma of fundic gland type#consists of#mixed proliferation of oxyntic and chief cells
#16628
middle Confidence
Subject:
Nucleolar_Organizer_Region
(Nucleolar Organizing Region (Chromosome Region))
→
is_investigated_as
→
Object:
ocular_adnexal_lymphoid_hyperplasia
(Disease phenotype)
Original: expression of proliferative cell nuclear antigen and Nuclear Organizer Region#investigates#ocular adnexal lymphoid hyperplasia
#16627
middle Confidence
Subject:
PCNA
(Proliferation-associated nuclear antigen (protein))
→
is_investigated_as
→
Object:
ocular_adnexal_lymphoid_hyperplasia
(Disease phenotype)
Original: expression of proliferative cell nuclear antigen and Nuclear Organizer Region#investigates#ocular adnexal lymphoid hyperplasia
#16626
middle Confidence
Subject:
Immunohistochemistry
(Immunohistochemistry)
→
contributes_to
→
Object:
diagnosis_of_SGC_by_staining_for_AR441
(AR441 staining for diagnosis of SGC)
Original: immunohistochemistry#contributes to#diagnosis of SGC by staining for adipophilin or AR441
#16625
middle Confidence
Subject:
Immunohistochemistry
(Immunohistochemistry)
→
contributes_to
→
Object:
diagnosis_of_SGC_by_staining_for_adipophilin
(Diagnosis of SGC by lipoglobulin staining)
Original: immunohistochemistry#contributes to#diagnosis of SGC by staining for adipophilin or AR441
#16624
middle Confidence
Subject:
silver_colloid_staining_technique
(Silver gel staining technique)
→
Assess
→
Object:
proliferative_potential_of_central_neurocytoma
(Central neuroblastoma proliferation potential)
Original: silver colloid staining technique#assesses#proliferative potential of central neurocytoma
#16623
middle Confidence
Subject:
carcinomatous_tissue
(Cancer tissue)
→
shows
→
Object:
positive_reaction_of_ER
(ER positive reaction)
Original: Carcinomatous tissues#show#higher DNA content/ AgNOR content/ and positive reaction of CEA and ER than normal tissue
#16622
middle Confidence
Subject:
carcinomatous_tissue
(Cancer tissue)
→
shows
→
Object:
positive_reaction_of_CEA
(CEA positive reaction)
Original: Carcinomatous tissues#show#higher DNA content/ AgNOR content/ and positive reaction of CEA and ER than normal tissue
#16621
middle Confidence
Subject:
carcinomatous_tissue
(Cancer tissue)
→
shows
→
Object:
higher_AgNOR_content
(AgNOR content)
Original: Carcinomatous tissues#show#higher DNA content/ AgNOR content/ and positive reaction of CEA and ER than normal tissue
#16620
middle Confidence
Subject:
carcinomatous_tissue
(Cancer tissue)
→
shows
→
Object:
higher_DNA_content
(DNA content)
Original: Carcinomatous tissues#show#higher DNA content/ AgNOR content/ and positive reaction of CEA and ER than normal tissue
#16619
middle Confidence
Subject:
NORA_values
(Nucleolar organizer region related parameters)
→
confirm
→
Object:
parathyroid_lesions
(Parathyroid disease)
Original: NORA values#confirm#AgNOR analysis as an additional tool for parathyroid lesions
#16618
middle Confidence
Subject:
NORA_values
(Nucleolar organizer region related parameters)
→
confirm
→
Object:
AgNOR_analysis_as_additional_tool
(AgNOR Analysis Tools)
Original: NORA values#confirm#AgNOR analysis as an additional tool for parathyroid lesions
#16617
middle Confidence
Subject:
p53_staining
(Protein expression status)
→
is_positive_in
→
Object:
dysplasia_controls
(Control group)
Original: p53 staining#is positive in#100% of dysplasia controls
#16616
middle Confidence
Subject:
chemrad
(Combined chemoradiotherapy regimen)
→
is_used_as
→
Object:
neoadjuvant_treatment
(Neoadjuvant therapy)
Original: chemrad#is used as#neoadjuvant treatment for esophageal adenocarcinoma or squamous cell carcinoma
#16615
middle Confidence
Subject:
chemrad
(Combined chemoradiotherapy regimen)
→
is_used_as
→
Object:
neoadjuvant_treatment
(Neoadjuvant therapy)
Original: chemrad#is used as#neoadjuvant treatment for esophageal adenocarcinoma or squamous cell carcinoma
#16614
middle Confidence
Subject:
protein_over-expression
(Protein expression status)
→
is_found_in
→
Object:
carcinomas
(Tumor diseases)
Original: protein over-expression#is found in#carcinomas by A0485 and CB11 antibodies
#16613
middle Confidence
Subject:
ACKD-RCC
(Kidney tumors)
→
studied_for
→
Object:
prognostic_features
(Prognostic features)
Original: ACKD-RCC#is studied for#clinicopathologic/ IHC/ histogenetic/ and prognostic features